Literature DB >> 31401441

Binding recognition of substrates in NS2B/NS3 serine protease of Zika virus revealed by molecular dynamics simulations.

Bodee Nutho1, Thanyada Rungrotmongkol2.   

Abstract

Zika virus (ZIKV) has become a global public health concern. The recent epidemiological data has revealed a possible association of ZIKV infection with more serious complications, particularly for Guillain-Barré syndrome in adults and microcephaly in newborn children. Till now, there is no vaccine or effective drug commercially available to combat with ZIKV infection. An attractive drug target for the ZIKV treatment is the NS2B/NS3 serine protease, which is essential for viral polyprotein processing. Herein, classical molecular dynamics (MD) simulations were performed on the ZIKV NS2B/NS3 serine protease in complex with four peptide substrates to investigate the binding recognition and protein-substrate interactions. The obtained results indicate that the P1 and P2 positions of the substrate play a significant role in binding with the protease enzyme, while the P3 and P4 positions show a minor contribution in binding interaction. Moreover, the binding free energy calculation based on the MM/PBSA method suggests that among the four similar peptide substrates, the peptide Ac-D-RKOR-ACC displays the strongest binding affinity towards the ZIKV protease due to the high energy contribution at the S2 subsite particularly for the NS3 residue D75 with the P2(O) residue of this substrate, which is in line with the experimental data. Thus, the information derived from MD simulations presented here would be useful for the design of potent protease inhibitors.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular dynamics; NS2B/NS3 serine protease; Substrate specificity; Zika virus

Mesh:

Substances:

Year:  2019        PMID: 31401441     DOI: 10.1016/j.jmgm.2019.08.001

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  5 in total

1.  A proteomics-MM/PBSA dual approach for the analysis of SARS-CoV-2 main protease substrate peptide specificity.

Authors:  Gloria Gallo; Uilla Barcick; Camila Coelho; Murilo Salardani; Maurício F Camacho; Daniela Cajado-Carvalho; Flávio V Loures; Solange M T Serrano; Leon Hardy; André Zelanis; Martin Würtele
Journal:  Peptides       Date:  2022-05-26       Impact factor: 3.867

2.  C-Terminal Extended Hexapeptides as Potent Inhibitors of the NS2B-NS3 Protease of the ZIKA Virus.

Authors:  Suyash Pant; Nihar R Jena
Journal:  Front Med (Lausanne)       Date:  2022-07-06

3.  Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms.

Authors:  Bodee Nutho; Panupong Mahalapbutr; Kowit Hengphasatporn; Nawanwat Chainuwong Pattaranggoon; Nattapon Simanon; Yasuteru Shigeta; Supot Hannongbua; Thanyada Rungrotmongkol
Journal:  Biochemistry       Date:  2020-04-24       Impact factor: 3.162

4.  Structure-Activity Relationships and Molecular Docking Analysis of Mcl-1 Targeting Renieramycin T Analogues in Patient-derived Lung Cancer Cells.

Authors:  Korrakod Petsri; Masashi Yokoya; Sucharat Tungsukruthai; Thanyada Rungrotmongkol; Bodee Nutho; Chanida Vinayanuwattikun; Naoki Saito; Matsubara Takehiro; Ryo Sato; Pithi Chanvorachote
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

5.  In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach.

Authors:  Muthu Kumar Thirunavukkarasu; Utid Suriya; Thanyada Rungrotmongkol; Ramanathan Karuppasamy
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.